Infliximab Biosimilar - Research Grade
Catalogue Number: ICH4006-ICB
| Manufacturer: | IchorBio |
| Type: | Recombinant Monoclonal |
| Alias: | Cachectin, TNFa, Tumor necrosis factor ligand superfamily member 2, Tnfsf2 |
| Shipping Condition: | Blue Ice |
| Unit(s): | 10 mg, 20 mg, 5 mg, 50 mg, 1 mg, 100 mg, 200 mg |
| Host name: | |
| Clone: | |
| Isotype: | IgG1, kappa |
| Immunogen: |
Description
Description: Infliximab biosimilar is a chimeric IgG1κ monoclonal antibody (composed of human constant and murine variable regions) specific for human tumor necrosis factor-alpha (TNFα). It has a molecular weight of approximately 149.1 kilodaltons. Infliximab biosimilar is produced by a recombinant cell line cultured by suspension culture and is purified by a series of steps that includes measures to inactivate and remove viruses.
Additional Text
Gene Name
TNF
Gene ID
7124
Uniprot ID
P01375
Purification
Protein A/G Purified
Concentration
1-5 mg/ml
Antibody Clonality
Recombinant Monoclonal
Storage Note
Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
ICH4006 Datasheet
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations